Skip to main content
Clinical Trials/NCT01716273
NCT01716273UnknownNot Applicable

A Randomised Controlled Trial to Investigate the Clinical and Cost-effectiveness of White Granulated Sugar Dressing Compared With Standard Treatment in the Management of Exudating Wounds With Parallel Economic Evaluation

Moses Murandu2 sites in 1 country108 target enrollmentStarted: June 1, 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
108
Locations
2
Primary Endpoint
Time to debridement of wound

Study Overview

Brief Summary

How effective is sugar in reducing the debriding of sloughy, necrotic or infected exudating wounds compared with standard treatment?

Detailed Description

Patients for whom all the following apply:

Have an exudating wound sizes 5cm2 and 40cm2 A minimum of 25% slough, infected and necrotic tissue No dry necrotic eschar present Ankle Brachial Pressure Index of greater than 0.6 Are over 18 years Independently and willingly consent

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Exudating wound sizes 5cm2 and 40cm2
  • A minimum of 25% slough, infected and necrotic tissue
  • No dry necrotic eschar
  • Ankle Brachial Pressure Index of greater than 0.6
  • Age over 18 years
  • Able to independently and willingly consent

Exclusion Criteria

  • Participants in a trial evaluating other therapies for their wound
  • Have previously been in this trial
  • Women who are pregnant
  • Participants not able to tolerate daily dressing change

Outcomes

Primary Outcomes

Time to debridement of wound

Time Frame: 4 weeks

wounds will be photographed at entry into the study there after weekly till end of study at 4 weeks

Secondary Outcomes

  • Reduction in wound surface area(4 weeks)

Investigators

Sponsor
Moses Murandu
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Moses Murandu

PhD student

University Hospital Birmingham

Study Sites (2)

Loading locations...

Similar Trials